Adherence, Persistence, and Switching Among People Prescribed Sodium Glucose Co-transporter 2 Inhibitors: A Nationwide Retrospective Cohort Study. https://t.co/ChJZrE813q
RT @ZANFINA: New study using Australian linked data showing that “empagliflozin was associated with better adherence and persistence rates…
RT @ZANFINA: New study using Australian linked data showing that “empagliflozin was associated with better adherence and persistence rates…
RT @AdvancesTherapy: Just published: "Adherence, Persistence, and Switching Among People Prescribed Sodium Glucose Co-transporter 2 Inhibit…
Adherence, Persistence, and Switching Among People Prescribed Sodium Glucose Co-transporter 2 Inhibitors: A Nationwide Retrospective Cohort Study. https://t.co/ChJZrEpCs0
Just published: "Adherence, Persistence, and Switching Among People Prescribed Sodium Glucose Co-transporter 2 Inhibitors: A Nationwide Retrospective Cohort Study" #SGLT2 #diabetes. Read the full paper here: https://t.co/5grPvzP0RR https://t.co/7BDz7vgOVy
New study using Australian linked data showing that “empagliflozin was associated with better adherence and persistence rates and a lower likelihood of switching compared with dapagliflozin” https://t.co/FZ5OKmHxA3 @Monash_SPHPM @MonashMore @Roasenso